266
Views
16
CrossRef citations to date
0
Altmetric
Commentary

Prevention of cervical and breast cancer mortality in low- and middle-income countries: a window of opportunity

&
Pages 381-386 | Published online: 03 Jul 2019

References

  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
  • Allemani C, Matsuda T, Carlo VD, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–1075. doi:10.1016/S0140-6736(17)33326-329395269
  • Vaccarella S, Laversanne M, Ferlay J, Bray F. Cervical cancer in Africa, Latin America and the Caribbean and Asia: regional inequalities and changing trends. Int J Cancer. 2017;141(10):1997–2001. doi:10.1002/ijc.3090128734013
  • Schiffman M, Doorbar J, Wentzensen N, et al. Carcinogenic human papillomavirus infection. Nat Rev Dis Primer. 2016;2:16086. doi:10.1038/nrdp.2016.86
  • Vanderpuye V, Grover S, Hammad N, et al. An update on the management of breast cancer in Africa. Infect Agent Cancer. 2017;12(1). doi:10.1186/s13027-017-0124-y
  • Ginsburg O, Bray F, Coleman MP, et al. The global burden of women’s cancers: a grand challenge in global health. Lancet Lond Engl. 2017;389(10071):847–860. doi:10.1016/S0140-6736(16)31392-7
  • Sankaranarayanan R. Screening for cancer in low- and middle-income countries. Ann Glob Health. 2014;80(5):412. doi:10.1016/j.aogh.2014.09.01425512156
  • Holme F, Kapambwe S, Nessa A, Basu P, Murillo R, Jeronimo J. Scaling up proven innovative cervical cancer screening strategies: challenges and opportunities in implementation at the population level in low- and lower-middle-income countries. Int J Gynaecol Obstet. 2017;138(Suppl 1):63–68. doi:10.1002/ijgo.1218528691331
  • World Health Organization (WHO). Noncommunicable diseases country profiles 2018. WHO. http://www.who.int/nmh/publications/ncd-profiles-2018/en/. Accessed 3 5, 2019.
  • Luciani S, Bruni L, Agurto I, Ruiz-Matus C. HPV vaccine implementation and monitoring in Latin America. Salud Pública México. 2018;60(6,nov–dic):683. doi:10.21149/9090
  • Bruni L, Barrionuevo-Rosas L, Albero G, et al. ICO/IARC information centre on HPV and cancer (HPV information centre). Human papillomavirus and related diseases in the world. Summary Report. 2017 7 27 .
  • Horton S, Gauvreau CL. Cancer in low- and middle-income countries: an economic overview In: Gelband H, Jha P, Sankaranarayanan R, Horton S, editors. Cancer: Disease Control Priorities, Third Edition (Volume 3). Washington (DC): The International Bank for Reconstruction and Development/The World Bank; 2015 Available from: http://www.ncbi.nlm.nih.gov/books/NBK343620/. Accessed 225, 2019.
  • Murillo R, Díaz S, Perry F, et al. Increased breast cancer screening and downstaging in Colombian women: a randomized trial of opportunistic breast-screening: downstaging with opportunistic screening for breast cancer in Colombia. Int J Cancer. 2016;138(3):705–713. doi:10.1002/ijc.2980126264446
  • Harford JB, Otero IV, Anderson BO, et al. Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the breast health global initiative. Breast Edinb Scotl. 2011;20(Suppl 2):S20–S29. doi:10.1016/j.breast.2011.02.007
  • Denny L, de Sanjose S, Mutebi M, et al. Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries. Lancet Lond Engl. 2017;389(10071):861–870. doi:10.1016/S0140-6736(16)31795-0
  • Bain C, Constant TH, Contreras I, Vega AMB, Jeronimo J, Tsu V. Model for early detection of breast cancer in low-resource areas: the experience in Peru. J Glob Oncol. 2018;(4):1–7. doi:10.1200/JGO.17.00006
  • Alba LH, Díaz S, Gamboa O, et al. Accuracy of mammography and clinical breast examination in the implementation of breast cancer screening programs in Colombia. Prev Med. 2018;115:19–25. doi:10.1016/j.ypmed.2018.08.00530092313
  • Jedy-Agba E, McCormack V, Adebamowo C, dos-Santos-Silva I. Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health. 2016;4(12):e923–e935. doi:10.1016/S2214-109X(16)30259-527855871
  • International Cancer Control Partnership. About the international cancer control partnership. International cancer control partnership. https://www.iccp-portal.org/what. Accessed 228, 2019.
  • Cervical Cancer Action. Visual inspection (VIA) for cervical cancer screening. Cervical cancer action. http://www.cervicalcanceraction.org/comments/map-slideshow-via.php. Accessed 2 28, 2019.
  • O’Neil DS, Keating NL, Dusengimana JMV, et al. Quality of breast cancer treatment at a rural cancer center in Rwanda. J Glob Oncol. 2018;(4):1–11. doi:10.1200/JGO.2016.008672
  • Toliman PJ, Kaldor JM, Badman SG, et al. Performance of clinical screening algorithms comprising point-of-care HPV-DNA testing using self-collected vaginal specimens, and visual inspection of the cervix with acetic acid, for the detection of underlying high-grade squamous intraepithelial lesions in Papua New Guinea. Papillomavirus Res. 2018;6:70–76. doi:10.1016/j.pvr.2018.10.00930391365
  • Espina C, McKenzie F, dos-Santos-Silva I. Delayed presentation and diagnosis of breast cancer in African women: a systematic review. Ann Epidemiol. 2017;27(10):659–671.e7. doi:10.1016/j.annepidem.2017.09.00729128086
  • Arrossi S, Thouyaret L, Laudi R, et al. Implementation of HPV-testing for cervical cancer screening in programmatic contexts: the Jujuy demonstration project in Argentina. Int J Cancer. 2015;137(7):1709–1718. doi:10.1002/ijc.2953025807897
  • Drummond JL, Were MC, Arrossi S, Wools-Kaloustian K. Cervical cancer data and data systems in limited-resource settings: challenges and opportunities. Int J Gynecol Obstet. 2017;138:33–40. doi:10.1002/ijgo.12192
  • Pan American Health Organization (PAHO). PAHO eHealth: eHealth strategy and plan of action (2012–2017). Pan American Health Organization/World Health Organization. [ Published 11 8, 2011]. https://www.paho.org/ict4health/index.php?option=com_content&view=article&id=54:estrategia-y-plan-de-accion-sobre-esalud-2012-2017&Itemid=146&lang=en. Accessed 225, 2019.
  • Dickerson LK, Rositch AF, Lucas S, Harvey SC. Pilot educational intervention and feasibility assessment of breast ultrasound in rural South Africa. J Glob Oncol. 2017;3(5):502–508. doi:10.1200/JGO.2016.00808629094089
  • Jeronimo J, Holme F, Slavkovsky R, Camel C. Implementation of HPV testing in Latin America. J Clin Virol. 2016;76(Suppl 1):S69–SS73. doi:10.1016/j.jcv.2015.11.03526699418
  • PATH. Ongoing PATH analysis of country data collected in Guatemala and Honduras. PATH. Seattle, WA 1 2019.
  • Unger-Saldaña K, Ventosa-Santaulària D, Miranda A, Verduzco-Bustos G. Barriers and explanatory mechanisms of delays in the patient and diagnosis intervals of care for breast cancer in Mexico. Oncologist. 2018;23(4):440–453. doi:10.1634/theoncologist.2017-043129284758
  • Ilaboya D, Gibson L, Musoke D. Perceived barriers to early detection of breast cancer in Wakiso District, Uganda using a socioecological approach. Glob Health. 2018;14(1):9. doi:10.1186/s12992-018-0326-0
  • Olasehinde O, Boutin-Foster C, Alatise OI, et al. Developing a breast cancer screening program in Nigeria: evaluating current practices, perceptions, and possible barriers. J Glob Oncol. 2017;3(5):490–496. doi:10.1200/JGO.2016.00764129094087
  • Islam RM, Billah B, Hossain MN, Oldroyd J. Barriers to cervical cancer and breast cancer screening uptake in low-income and middle-income countries: a systematic review. Asian Pac J Cancer Prev. 2017;18(7):1751–1763. doi:10.22034/APJCP.2017.18.7.175128749101
  • Moodley J, Constant D, Botha MH, van der Merwe FH, Edwards A, Momberg M. Exploring the feasibility of using mobile phones to improve the management of clients with cervical cancer precursor lesions. BMC Womens Health. 2019;19(1):2. doi:10.1186/s12905-018-0702-130616579
  • Linde DS, Andersen MS, Mwaiselage JD, Manongi R, Kjaer SK, Rasch V. Text messages to increase attendance to follow-up cervical cancer screening appointments among HPV-positive Tanzanian women (Connected2Care): study protocol for a randomised controlled trial. Trials. 2017;18(1). doi:10.1186/s13063-017-2215-x
  • Gurol-Urganci I, de Jongh T, Vodopivec-Jamsek V, Atun R, Car J; Cochrane Consumers and Communication Group, ed. Mobile phone messaging reminders for attendance at healthcare appointments. Cochrane Database Syst Rev. 2013. doi:10.1002/14651858.CD007458.pub3
  • Bukowski A, Chávarri-Guerra Y, Goss PE. The potential role of patient navigation in low- and middle-income countries for patients with cancer. JAMA Oncol. 2016;2(8):994–995. doi:10.1001/jamaoncol.2016.076627228333
  • Bittencourt L, Scarinci IC. Training community health workers to promote breast cancer screening in Brazil. Health Promot Int. 2017. doi:10.1093/heapro/dax058
  • Seidman G, Atun R. Does task shifting yield cost savings and improve efficiency for health systems? A systematic review of evidence from low-income and middle-income countries. Hum Resour Health. 2017;15(1). doi:10.1186/s12960-017-0200-9